Four Models of Telephone Support for Stimulant Recovery

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
David Farabee, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00744068
First received: August 28, 2008
Last updated: May 3, 2013
Last verified: May 2013
  Purpose

The overall objective of this research is to develop and refine empirically supported continuing care interventions that promote healthy behavior and sustained abstinence from illicit drug use.


Condition Intervention
Drug Addiction
Behavioral: Continuing Care Telephone Support

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Four Models of Telephone Support for Stimulant Recovery

Further study details as provided by University of California, Los Angeles:

Primary Outcome Measures:
  • Urinalyses [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]
  • Breathalyzer tests [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]
  • Self-report of drug or alcohol use [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]
  • Amount of Treatment Activities [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]
  • Length of Treatment Episode [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Addiction Severity Index (ASI) [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]
  • HIV Risk-taking Behavior Scale [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]
  • Concurrent Psychosocial Treatments [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]
  • Drug Avoidance Activities (DAA) Survey [ Time Frame: At 3 months and 12 months ] [ Designated as safety issue: No ]

Enrollment: 302
Study Start Date: April 2006
Study Completion Date: September 2011
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Structured Directive Telephone Support Calls
Behavioral: Continuing Care Telephone Support
Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.
Experimental: 2
Structured Non-Directive Telephone Continuing Care Support
Behavioral: Continuing Care Telephone Support
Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.
Experimental: 3
Unstructured Directive Telephone Support
Behavioral: Continuing Care Telephone Support
Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.
Experimental: 4
Unstructured Non-Directive Telephone Support
Behavioral: Continuing Care Telephone Support
Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.
No Intervention: 5

Detailed Description:

For treatment interventions to provide the desired result of long term abstinence, it is important to develop strategies to enhance the effectiveness of continued care approaches. We plan to conduct a prospective, randomized comparison of four models of counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program. Some 500 participants completing a 4-month Matrix Outpatient Model of stimulant abuse treatment will be randomly assigned to one of four counseling groups (n=100 per group): (1) unstructured/non-directive, (2) structured/non-directive, (3) unstructured/directive, or (4) structured/directive telephone counseling, or (5) a control group consisting of standard referral to Matrix aftercare, for a total sample size of 500. The two structured conditions will be based on the behavioral "prompts" identified by Farabee et al. (2002)* as being associated with drug avoidance. In the non-directive conditions, subjects will be allowed to state their own goals and how they intend to achieve them. In the directive conditions, the counselor will provide specific recommendations to help the subject adopt as many of the drug-avoidance activities as possible. Outcomes will be tracked for 12 months following completion of primary treatment (a total of 16 months after treatment admission) and will include measurement of participation in drug-avoidance activities (including aftercare participation) as well as self-reported and objective measures of substance use and related behavior change.

*Farabee, D., Rawson, R.A., & McCann, M. (2002). Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. Journal of Substance Abuse Treatment, 23, 343-350.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Males or females, 18-65 years of age.
  • Meet DSM-IV criteria (at the time of treatment admission) for cocaine or methamphetamine abuse/dependence.
  • Have completed the primary phase of treatment at a Matrix outpatient clinic.
  • Have telephone access throughout the study procedures.
  • Be able to understand and complete rating scales and to follow instructions.
  • Be willing to sign an informed consent form.

Exclusion Criteria:

  • Have participated in a treatment-related study conducted by the PI and colleagues during the previous 3 years and/or is currently enrolled in a treatment-related study.
  • Have any medical, legal, housing or transportation problem which would preclude either safe or consistent participation.
  • Have dropped out of the primary phase of treatment prior to completion.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00744068

Locations
United States, California
Twin Town Treatment Center
Los Alamitos, California, United States, 90720
UCLA Integrated Substance Abuse Programs
Los Angeles, California, United States, 90025
Matrix Institute on Addictions
Los Angeles, California, United States, 90025
Matrix Institute on Addictions
Rancho Cucamonga, California, United States, 91730
Twin Town Treatment Center
West Hollywood, California, United States, 90069
Matrix Institute on Addicitions
Woodland Hills, California, United States, 91364
Sponsors and Collaborators
University of California, Los Angeles
Investigators
Principal Investigator: David Farabee, Ph.D. UCLA Integrated Substance Abuse Programs
  More Information

Additional Information:
Publications:
Rawson, Richard, A. and The Methamphetamine Treatment Project Corporate Authors (In press). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. American Journal of Psychiatry.

Responsible Party: David Farabee, Professor, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT00744068     History of Changes
Other Study ID Numbers: R01 DA18208-01A1, R01DA018208
Study First Received: August 28, 2008
Last Updated: May 3, 2013
Health Authority: United States: Federal Government

Keywords provided by University of California, Los Angeles:
Stimulant
Drug treatment
Continuing care
Telephone support
Aftercare

Additional relevant MeSH terms:
Central Nervous System Stimulants
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on September 16, 2014